Table 1:

Time spent per patient at each CKD stage (mean years).

	Dapagliflozin (95% CrI)	Placebo (95% CrI)	Incremental (95% CrI)
CKD 1	0.04 (0.03, 0.06)	0.03 (0.02, 0.05)	0.01 (0.00, 0.03)	0.65 (0.41, 0.90)
CKD 2	0.58 (0.52, 0.64)	0.54 (0.47, 0.61)	0.04 (–0.04, 0.12)
CKD 3a	1.58 (1.48, 1.68)	1.42 (1.30, 1.53)	0.17 (0.04, 0.29)
CKD 3b	3.07 (2.88, 3.21)	2.64 (2.45, 2.80)	0.43 (0.27, 0.60)
CKD 4	2.48 (2.29, 2.63)	2.53 (2.30, 2.72)	–0.06 (–0.24, 0.13)	–0.23 (–0.45, 0.00)
CKD 5 (pre-KRT)	0.29 (0.24, 0.34)	0.34 (0.27, 0.41)	–0.05 (–0.11, 0.02)
Dialysis	0.63 (0.54, 0.73)	0.73 (0.61, 0.83)	–0.10 (–0.23, 0.03)
Transplant	0.16 (0.12, 0.20)	0.19 (0.14, 0.24)	–0.03 (–0.08, 0.02)